In Sub-Saharan Africa (SSA), stroke incidence rates are rising, outcomes are worse, and relatively younger people are affected compared with Caucasian populations. As stroke genomic discoveries and stroke biobanking activities grow in SSA, there is a need to identify, document, and develop approaches to address the ethical, legal, and social implications in an emerging African scientific landscape.
A: Nigeria
University of Ibadan/ College of Medicine, University of Ilorin/University of Ilorin Teaching Hospital, Federal Medical Centre, Bayero University/Aminu Kano Teaching Hospital, Ahmadu Bello University Teaching Hospital
B: Ghana
Kwameh Nkrumah University of Science and Technology, University of Ghana/Korle Bu Teaching Hospital
Non-African Collaborators
USA: Medical University of South Carolina
UK: Newcastle University